Home/Blog/Avesta presentation at Ketamine Conference 2024 in Oxford, UK

Avesta presentation at Ketamine Conference 2024 in Oxford, UK

Dr. Ladan Eshkevari was chosen to present at the Ketamine Conference 2024 in Oxford, UK in March 2024, hosted by the Ketamine & Related Compounds International Journal Club. Ketamine 2024 is a forum for top researchers and experienced and interested clinicians to learn from each other about the therapeutic use of ketamine and related compounds…

By Deborah Tan

Updated October 15, 2024

1 min read

Quick Answer

Dr. Ladan Eshkevari was chosen to present at the Ketamine Conference 2024 in Oxford, UK in March 2024, hosted by the Ketamine & Related Compounds International Journal Club.

Ketamine 2024 is a forum for top researchers and experienced and interested clinicians to learn from each other about the therapeutic use of ketamine and related compounds for affective disorders. Dr. Eshkevari was chosen to present her paper, “Efficacy of addition of the anti-inflammatory, IV Glutathione to standard Ketamine IV therapy in Major Depressive Disorder”.

References

Written by

Deborah Tan

Deborah is co-CEO of Avesta Ketamine and Wellness. She is dedicated to improving the patient experience and to expanding access for cutting-edge mental health treatments for patients suffering from treatment-resistant depression, generalized anxiety, PTSD and other mood disorders.

Co-authored by

Medically reviewed

RELATED CARE

On This Page